Testing chemotherapy efficacy in HER2 negative breast cancer using patient-derived spheroids

Abstract

The tissue spheroid model reflects current guideline treatment recommendations for HER2 negative breast cancer, whereas tested cell lines did not. This model represents a unique diagnostic method to select the most effective therapy out of several equivalent treatment options.